CRISPR-mediated gene editing for the surgeon scientist.

Tremendous advances have occurred in gene editing during the past 20 years with the development of a number of systems. The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated protein 9 (Cas9) system represents an exciting area of research. This review examines both the relevant studies pertaining to the history, current status, and modifications of this system, in comparison with other gene-editing systems and future applications, and limitations of the CRISPR-Cas9 gene-editing system, with a focus on applications of relevance to the surgeon scientist. The CRISPR-Cas9 system was described initially in 2012 for gene editing in bacteria and then in human cells, and since then, a number of modifications have improved the efficiency and specificity of gene editing. Clinical studies have been limited because further research is required to verify its safety in patients. Some clinical trials in oncology have opened, and early studies have shown that gene editing may have a particular role in the field of organ transplantation and in the care of trauma patients. Gene editing is likely to play an important role in future research in many aspects of the surgery arena.

• Publication year

  2019

• Venue

  Surgery

• Publication date

  2019-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.surg.2019.01.030PMID 30922545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Translation of CRISPR Genome Surgery to the Bedside for Retinal Diseases

  2018cited by this paper
• Genome-edited baby claim provokes international outcry

  2018cited by this paper
• CRISPR/Cas9 can mediate high-efficiency off-target mutations in mice in vivo

  2018cited by this paper
• Different Methods of Delivering CRISPR/Cas9 Into Cells.

  2018cited by this paper
• CRISPRlnc: a manually curated database of validated sgRNAs for lncRNAs

  2018cited by this paper
• Gene editing in the context of an increasingly complex genome

  2018cited by this paper
• The Current State and Future of CRISPR-Cas9 gRNA Design Tools

  2018cited by this paper
• Gene Editing on Center Stage.

  2018cited by this paper
• CRISPR base editors: genome editing without double-stranded breaks

  2018cited by this paper
• CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response

  2018cited by this paper
• Recent Advances in Therapeutic Genome Editing in China

  2018cited by this paper
• CRISPR/Cas9 Genome Editing of Epidermal Growth Factor Receptor Sufficiently Abolished Oncogenicity in Anaplastic Thyroid Cancer

  2018cited by this paper
• 
Genome Surgery and Gene Therapy in Retinal Disorders

  2017cited by this paper
• Genome editing in cardiovascular diseases

  2017cited by this paper
• Non-homologous DNA end joining and alternative pathways to double-strand break repair

  2017cited by this paper
• A communal catalogue reveals Earth’s multiscale microbial diversity

  2017cited by this paper
• Renal xenotransplantation: experimental progress and clinical prospects.

  2017cited by this paper
• Delivery technologies for genome editing

  2017cited by this paper
• Targeted Deletion of an Entire Chromosome Using CRISPR/Cas9.

  2017cited by this paper
• The Resurgence of Xenotransplantation

  2017cited by this paper
• Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells From GGTA1/CMAH/B4GalNT2, and SLA Class I Knockout Pigs

  2017cited by this paper
• Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair

  2017cited by this paper
• Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood

  2017cited by this paper
• Small molecules enhance CRISPR/Cas9-mediated homology-directed genome editing in primary cells

  2017cited by this paper
• No PERV transmission during a clinical trial of pig islet cell transplantation.

  2017cited by this paper
• Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease

  2017cited by this paper
• Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

  2016cited by this paper
• Gene Editing for Cancer Is Coming of Age

  2016cited by this paper
• Clinical Benefit of Islet Xenotransplantation for the Treatment of Type 1 Diabetes

  2016cited by this paper
• Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology.

  2016cited by this paper
• Application of CRISPR / Cas to the treatment of eye disease

  2016cited by this paper
• Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9.

  2016cited by this paper
• A Bridge to Somewhere: 25-day Survival After Pig-to-Baboon Liver Xenotransplantation.

  2016cited by this paper
• CRISPR gene-editing tested in a person for the first time

  2016cited by this paper
• Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives.

  2016cited by this paper
• The use of CRISPR/Cas associated technologies for cell transplant applications

  2016cited by this paper
• The control of DNA repair by the cell cycle

  2016cited by this paper
• Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.

  2016cited by this paper
• Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance

  2016cited by this paper
• Site-Specific Genome Engineering in Human Pluripotent Stem Cells

  2016cited by this paper
• The production of multi-transgenic pigs: update and perspectives for xenotransplantation

  2016cited by this paper
• Production of Human Albumin in Pigs Through CRISPR/Cas9-Mediated Knockin of Human cDNA into Swine Albumin Locus in the Zygotes

  2015cited by this paper
• CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells

  2015cited by this paper
• CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice

  2015cited by this paper
• Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution

  2015cited by this paper
• Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids

  2015cited by this paper
• Blockade of CD40–CD154 Costimulatory Pathway Promotes Long‐Term Survival of Full‐Thickness Porcine Corneal Grafts in Nonhuman Primates: Clinically Applicable Xenocorneal Transplantation

  2015cited by this paper
• Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides

  2015cited by this paper
• Efficient and allele-specific genome editing of disease loci in human iPSCs.

  2015cited by this paper
• Inhibition of non-homologous end joining increases the efficiency of CRISPR/Cas9-mediated precise [TM: inserted] genome editing

  2015cited by this paper
• Pre‐clinical heterotopic intrathoracic heart xenotransplantation: a possibly useful clinical technique

  2015cited by this paper
• Identifying drug-target selectivity of small-molecule CRM1/XPO1 inhibitors by CRISPR/Cas9 genome editing.

  2015cited by this paper
• Current status of corneal xenotransplantation.

  2015cited by this paper
• Specific hepatic delivery of procollagen α1(I) small interfering RNA in lipid‐like nanoparticles resolves liver fibrosis

  2015cited by this paper
• Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

  2015cited by this paper
• Current status of pig heart xenotransplantation.

  2015cited by this paper
• Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR.

  2015cited by this paper
• Is the age of genetic surgery finally upon us?

  2015cited by this paper
• Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs.

  2015cited by this paper
• Present and future challenges of induced pluripotent stem cells

  2015cited by this paper
• Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9.

  2015cited by this paper
• Current status of pig lung xenotransplantation.

  2015cited by this paper
• In vivo genome editing using Staphylococcus aureus Cas9

  2015cited by this paper
• BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis

  2015cited by this paper
• Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells

  2014cited by this paper
• GUIDE-Seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases

  2014cited by this paper
• Considerations when investigating lncRNA function in vivo

  2014cited by this paper
• Creating Class I MHC–Null Pigs Using Guide RNA and the Cas9 Endonuclease

  2014cited by this paper
• In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9

  2014cited by this paper
• RNAi screening comes of age: improved techniques and complementary approaches

  2014cited by this paper
• Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand

  2014cited by this paper
• Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR–Cas9 system

  2014cited by this paper
• CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.

  2014cited by this paper
• Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation.

  2014cited by this paper
• Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9

  2014cited by this paper
• Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification

  2014cited by this paper
• Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing.

  2014cited by this paper
• Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

  2014cited by this paper
• Organ Shortage: The Greatest Challenge Facing Transplant Medicine

  2014cited by this paper
• Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac

  2014cited by this paper
• E-CRISP: fast CRISPR target site identification

  2014cited by this paper
• RNAi Factors are Present and Active in Human Cell Nuclei

  2014cited by this paper
• Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

  2013cited by this paper
• TALEN-based gene correction for epidermolysis bullosa.

  2013cited by this paper
• ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.

  2013cited by this paper
• High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity

  2013cited by this paper
• Protospacer recognition motifs

  2013cited by this paper
• Nucleotide-resolution DNA double-strand breaks mapping by next-generation sequencing

  2013cited by this paper
• Multiplex Genome Engineering Using CRISPR/Cas Systems

  2013cited by this paper
• One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.

  2013cited by this paper
• CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering

  2013cited by this paper
• Molecular mechanisms of RNA interference.

  2013cited by this paper
• RNA-Guided Human Genome Engineering via Cas9

  2013cited by this paper
• CRISPR RNA-guided activation of endogenous human genes

  2013cited by this paper
• DNA targeting specificity of RNA-guided Cas9 nucleases

  2013cited by this paper
• RNA-guided genetic silencing systems in bacteria and archaea

  2012cited by this paper
• Hematopoietic stem cell engineering at a crossroads.

  2012cited by this paper
• A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

  2012cited by this paper
• Playing the end game: DNA double-strand break repair pathway choice.

  2012cited by this paper
• Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria

  2012cited by this paper

• Long non-coding RNA ZFAS1 is a major regulator of epithelial-mesenchymal transition through miR-200/ZEB1/E-cadherin, vimentin signaling in colon adenocarcinoma

  2021cites this paper
• CRISPR and the potential for human genome editing.

  2019cites this paper
• Atomic bomb and clustered regularly interspaced short palindromic repeats gene editing technology.

  2019cites this paper
• Reply to: Atomic bomb and CRISPR gene editing technology.

  2019cites this paper
• Kompatscher Regulation of Toll-like receptors signaling by vesicle transport protein ZFYVE 27

  2019cites this paper
• The identification of long non-coding RNA ZFAS1 through an exploratory RNA-sequencing analysis and its association with epithelial-to-mesenchymal transition in colon cancer adenocarcinoma.

  2019cites this paper